Skip to main content
Fig. 3 | Translational Neurodegeneration

Fig. 3

From: Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers

Fig. 3

CSF levels in the different clinical subgroups (NC, PMC, PPA and bvFTD). (a) neurosecretory protein VGF (VGF), (b) neuronal pentraxin receptor (NPTXR), (c) transmembrane protein 132D (TMEM132D), (d) prodynorphin (PDYN), (e) neurofilament medium polypeptide (NF-M) and (f) tenascin-R (TN-R). Stars indicate significant differences, * p < 0.05, ** p < 0.01 and ***p < 0.001 NC – Non-carriers, PMC – Presymptomatic mutation carriers, PPA – Primary progressive aphasia, bvFTD – Behavioural variant FTD

Back to article page

Translational Neurodegeneration

ISSN: 2047-9158

Contact us